Author

K Tomita

Observed name: K. Tomita

Observed institution: Radboud University Medical Center

OpenAlex ID: A5110095848

Cadherin switching in human prostate cancer progression.

2000 · K Tomita, A van Bokhoven, et al. · PubMed · 416

Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer.

2000 · S Muto, S Horie, et al. · PubMed · 77

The prognostic value of E‐cadherin and the cadherin‐associated molecules α‐, β‐, γ‐catenin and p120ctn in prostate cancer specific survival: A long‐term follow‐up study

2007 · I.M. van Oort, K. Tomita, et al. · The Prostate · 57

Enhanced tumor metastases in rats following cryosurgery of primary tumor.

1982 · T Yamashita, K Hayakawa, et al. · PubMed · 56

The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.

1995 · H Tsuchiya, S Katsuo, et al. · PubMed · 19

Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.

1997 · H Tsuchiya, C Sunayama, et al. · PubMed · 14

[Prognostic significance of histopathological findings (including lymphocyte infiltration) in renal cell carcinoma].

1996 · K Tomita, N Okui, et al. · PubMed · 2

[Breast cancer at the site of an implanted pacemaker].

1999 · K Tanaka, K Ohyama, et al. · PubMed · 1

Effect of specific targeting of a modified salmonella typhymurium on cancer metastases.

2010 · K. Hayashi, M. Zhao, et al. · Journal of Clinical Oncology

460N-cadherin expression is associated with bladder cancer progression and poor prognosis

2005 · K. Tomita, H. Kume, et al. · European Urology Supplements

Possible clinical significance of K-ras mutation for subsequent polyp and/or colorectal tumor after endoscopic polypectomy

1999 · K Tomita, J. Kanou, et al.

[Human tumor clonogenic assay in osteosarcoma and its clinical evaluation].

1986 · K Tomita, A Yokogawa, et al. · PubMed

Works count: 12

Citation count: 642

H-index: 6

I10-index: 6